Tonix Pharma (TNXP) Reports Q4 Loss of $2.08/Share

Tonix Pharma (NASDAQ: TNXP) reported Q4 EPS of ($2.08), versus ($7.96) reported last year.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• Carnival shares drop despite earnings beat on weak guidance